Cardiology

Researchers identify new target for common heart condition

Researchers have found new evidence that metabolic stress can increase the onset of atrial arrhythmias, such as atrial fibrillation (AF), a common heart condition that causes an irregular and often abnormally fast heart rate. ...

Medications

Xarelto's approval expanded

(HealthDay)—Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism.

Cardiology

Apixaban superior to warfarin across range of patient risk scores

A new anticoagulant called apixaban is superior to warfarin in preventing stroke with consistent effects across a wide range of stroke and bleeding risk in patients with atrial fibrillation, according to Duke University Medical ...

Cardiology

Implantable defibrillators lead to decrease in cardiac arrests

Implantable cardioverter defibrillators account for one-third of the decrease in cardiac arrests caused by ventricular fibrillation in North-Holland, according to research in Circulation, an American Heart Association journal.

Medications

Drug approved to treat high blood pressure

(HealthDay) -- The high blood pressure drug Toprol XL has been combined with a low-dose diuretic to form Dutoprol (metoprolol succinate extended release/hyrdrochlorothiazide), which has been approved by the U.S. Food and ...

Medications

FDA adds more warnings to antidepressant's label

(HealthDay) -- In a follow-up to a warning that high doses of the popular antidepressant Celexa can cause potentially fatal abnormal heart rhythms, the U.S. Food and Drug Administration has issued new dosing and use recommendations.

page 15 from 16